Home
EDSA
EDSA News

Latest Edesa Biotech Inc. (EDSA) News on January 19, 2025

Edesa Biotech And 2 Other Promising US Penny Stocks For Your Radar

Simply Wall St.

a month ago

Edesa Biotech And 2 Other Promising US Penny Stocks For Your Radar

Edesa Biotech Reports Fiscal Year 2024 Results

GlobeNewswire

a month ago

Edesa Biotech Reports Fiscal Year 2024 Results

Edesa Biotech’s Founder Makes Strategic Investment in the Company

GlobeNewswire

3 months ago

Edesa Biotech’s Founder Makes Strategic Investment in the Company

Edesa Biotech Announces Upcoming Conference Schedule

GlobeNewswire

3 months ago

Edesa Biotech Announces Upcoming Conference Schedule

EDSA: EB05 Selected for BARDA-Funded Study in ARDS…

Zacks Small Cap Research

5 months ago

EDSA: EB05 Selected for BARDA-Funded Study in ARDS…

BARDA Selects Edesa Biotech's Drug for U.S. Funded Platform Trial in General ARDS

ACCESSWIRE

7 months ago

BARDA Selects Edesa Biotech's Drug for U.S. Funded Platform Trial in General ARDS

EDSA: Preparing IND for Phase 2 Trial of EB06 in Vitiligo

Zacks Small Cap Research

8 months ago

EDSA: Preparing IND for Phase 2 Trial of EB06 in Vitiligo

Edesa Biotech Reports Fiscal 2nd Quarter 2024 Results

ACCESSWIRE

8 months ago

Edesa Biotech Reports Fiscal 2nd Quarter 2024 Results

Edesa Biotech to Participate in Bloom Burton Healthcare Investor Conference

ACCESSWIRE

9 months ago

Edesa Biotech to Participate in Bloom Burton Healthcare Investor Conference

Edesa Biotech to Participate in Upcoming Investor Conferences

ACCESSWIRE

10 months ago

Edesa Biotech to Participate in Upcoming Investor Conferences

Edesa Biotech to Participate in HC Wainwright Autoimmune & Inflammatory Conference

ACCESSWIRE

10 months ago

Edesa Biotech to Participate in HC Wainwright Autoimmune & Inflammatory Conference

Edesa Biotech to Participate in Barclays Global Healthcare Conference

ACCESSWIRE

10 months ago

Edesa Biotech to Participate in Barclays Global Healthcare Conference

Edesa Biotech to Participate in Upcoming Dermatology Meetings

ACCESSWIRE

10 months ago

Edesa Biotech to Participate in Upcoming Dermatology Meetings

Zacks Small Cap Research

a year ago

EDSA: Development of EB05 in ARDS Continues…

Edesa Biotech Reports Fiscal 1st Quarter 2024 Results

ACCESSWIRE

a year ago

Edesa Biotech Reports Fiscal 1st Quarter 2024 Results

Aware Adds Product Strategy Innovator to Executive Team to Further Align Biometric Platform and Vision with Market Growth

GlobeNewswire

a year ago

Aware Adds Product Strategy Innovator to Executive Team to Further Align Biometric Platform and Vision with Market Growth

TSR (NASDAQ:TSRI) Is Experiencing Growth In Returns On Capital

Simply Wall St.

a year ago

TSR (NASDAQ:TSRI) Is Experiencing Growth In Returns On Capital

Newsfile

a year ago

PetVivo Holdings, Inc. Invites You to Join Us at The Microcap Conference

PETVIVO HOLDINGS, INC. TO EXHIBIT AT VETERINARY MEETING AND EXPO CONFERENCE IN ORLANDO, FLORIDA

GlobeNewswire

a year ago

PETVIVO HOLDINGS, INC. TO EXHIBIT AT VETERINARY MEETING AND EXPO CONFERENCE IN ORLANDO, FLORIDA

The Container Store Group, Inc. Provides Business Update Ahead of 2024 ICR Conference Presentation

Business Wire

a year ago

The Container Store Group, Inc. Provides Business Update Ahead of 2024 ICR Conference Presentation

Edesa Biotech to Participate in Dermatology Summit and JP Morgan Week

ACCESSWIRE

a year ago

Edesa Biotech to Participate in Dermatology Summit and JP Morgan Week

New to The Street TV Announces the Interviews of Four Corporate Guest, Episode 541, Airing on Bloomberg TV as Sponsored Programming, Tonight, Thursday, January 4, 2024, 9:30 PM PT

GlobeNewswire

a year ago

New to The Street TV Announces the Interviews of Four Corporate Guest, Episode 541, Airing on Bloomberg TV as Sponsored Programming, Tonight, Thursday, January 4, 2024, 9:30 PM PT

Meihua International Medical Technologies Co., Ltd. Announces Closing of Initial $6 Million Tranche of Potential $50.5 Million Maximum Offering

PR Newswire

a year ago

Meihua International Medical Technologies Co., Ltd. Announces Closing of Initial $6 Million Tranche of Potential $50.5 Million Maximum Offering

EDSA: Updated Phase 3 Protocol for EB05 Trial Approved by Canadian Regulators…

Zacks Small Cap Research

a year ago

EDSA: Updated Phase 3 Protocol for EB05 Trial Approved by Canadian Regulators…

Yoshitsu Co., Ltd Reports First Six Months of Fiscal Year 2024 Financial Results

PR Newswire

a year ago

Yoshitsu Co., Ltd Reports First Six Months of Fiscal Year 2024 Financial Results

Clarion Clinics Receives Ethics Board Endorsement for the First Dedicated Psychedelic-Assisted Therapy Clinic in Australia

GlobeNewswire

a year ago

Clarion Clinics Receives Ethics Board Endorsement for the First Dedicated Psychedelic-Assisted Therapy Clinic in Australia

LiveOne (Nasdaq: LVO) Issues Fiscal 2025 Revenue Guidance of $140 - $155M with $16 - $20M of Adjusted EBITDA*

GlobeNewswire

a year ago

LiveOne (Nasdaq: LVO) Issues Fiscal 2025 Revenue Guidance of $140 - $155M with $16 - $20M of Adjusted EBITDA*

Edesa Biotech Reports Fiscal Year 2023 Results

ACCESSWIRE

a year ago

Edesa Biotech Reports Fiscal Year 2023 Results

Velo3D Announces Leadership Transition and Commencement of Strategic Business Review

Business Wire

a year ago

Velo3D Announces Leadership Transition and Commencement of Strategic Business Review

Aesthetic Medical International Announces Change of Auditor and Change of Director

GlobeNewswire

a year ago

Aesthetic Medical International Announces Change of Auditor and Change of Director

Here's Why Rubicon Technologies, Inc. (RBT) Is a Great 'Buy the Bottom' Stock Now

Zacks

a year ago

Here's Why Rubicon Technologies, Inc. (RBT) Is a Great 'Buy the Bottom' Stock Now

Clarus Reports Status of HAP Trading Short-Swing Profit Litigation

GlobeNewswire

a year ago

Clarus Reports Status of HAP Trading Short-Swing Profit Litigation

Lavie Bio Announces a Distribution Agreement with WinField United Canada for its Bio-Inoculant Seed Treatment Yalos™

PR Newswire

a year ago

Lavie Bio Announces a Distribution Agreement with WinField United Canada for its Bio-Inoculant Seed Treatment Yalos™

Gulf Island Announces Share Repurchase Program

GlobeNewswire

a year ago

Gulf Island Announces Share Repurchase Program

New Strong Sell Stocks for November 24th

Zacks

a year ago

New Strong Sell Stocks for November 24th

Edesa Biotech Reports Final Phase 2b Results for Dermatitis Study

ACCESSWIRE

a year ago

Edesa Biotech Reports Final Phase 2b Results for Dermatitis Study

New to The Street Announces Episode 530 with Six Corporate Interviews, Airing on the Fox Business Network, Monday, November 20, 2023, at 10:30 PM PT

GlobeNewswire

a year ago

New to The Street Announces Episode 530 with Six Corporate Interviews, Airing on the Fox Business Network, Monday, November 20, 2023, at 10:30 PM PT

Cara Therapeutics, Inc. (NASDAQ:CARA) Q3 2023 Earnings Call Transcript

Insider Monkey

a year ago

Cara Therapeutics, Inc. (NASDAQ:CARA) Q3 2023 Earnings Call Transcript

Analysts Have Been Trimming Their Charge Enterprises, Inc. (NASDAQ:CRGE) Price Target After Its Latest Report

Simply Wall St.

a year ago

Analysts Have Been Trimming Their Charge Enterprises, Inc. (NASDAQ:CRGE) Price Target After Its Latest Report

Oncolytics Provides Update on Pancreatic Cancer Program for Pelareorep

CNW Group

a year ago

Oncolytics Provides Update on Pancreatic Cancer Program for Pelareorep

Thomson Reuters StreetEvents

a year ago

Q3 2023 FreightCar America Inc Earnings Call

FreightCar America Inc (RAIL) Reports Q3 2023 Earnings: Gross Margin Expands Despite Revenue Decline

GuruFocus.com

a year ago

FreightCar America Inc (RAIL) Reports Q3 2023 Earnings: Gross Margin Expands Despite Revenue Decline

Molecular Templates Announces First Patient Dosed in Phase 1 Trial Evaluating MT-8421, a Novel Engineered Toxin Body Targeting CTLA-4, in Advanced Solid Tumors

GlobeNewswire

a year ago

Molecular Templates Announces First Patient Dosed in Phase 1 Trial Evaluating MT-8421, a Novel Engineered Toxin Body Targeting CTLA-4, in Advanced Solid Tumors

Rallybio Announces Acceptance of FNAIT Natural History Study Abstract for Presentation at the 65th American Society of Hematology Annual Meeting

Business Wire

a year ago

Rallybio Announces Acceptance of FNAIT Natural History Study Abstract for Presentation at the 65th American Society of Hematology Annual Meeting

Share on Social Networks: